2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

The Use of Kidneys with Acute Kidney Injury: The Good, the Bad and the Ugly.

C. Boffa,^1,2 F. van de Leemkolk,¹ E. Curnow,³ J. Gilbert,² E. Sharples,^1,2 R. Ploeg.^1,2
The Use of Perioperative Lactate Values as Markers for Adverse Outcomes in Liver Transplantation.

B. Rao,¹ A. Yoshida,³ M. Ibrahim,² S.-M. Jafri.²
The Use of Sofosbuvir (SOF)-Containing Direct Antiviral Agents (DAA)-Based Regimens Requires Increase in Tacrolimus (Tac) Doses in Kidney Transplant (KT) Recipients with Hepatitis C Virus (HCV) Infection.

N. Polanco Fernandez,¹ A. García Santiago,¹ M. Fernández Ruiz,² R. Muñoz,³ C. Alvarez Vazquez,⁴ A. Hernandez,¹ V. Mercado,¹ E. González Monte,¹ I. Fernández,³ J. Aguado,² M. Praga,¹ A. Andres.¹
The Use of Thromboelastography (TEG) in Preoperative Pediatric Liver Transplantation to Predict Postoperative Thrombotic Complications.

K. Curiel,¹ B. Wicklund,² K. Gonzalez,¹ W. Andrews,¹ V. Fioravanti,¹ R. Hendrickson.¹
The In Vivo Non-Invasive Long-Term Functional Assessment of Neuronal Regeneration in Vascularized Composite Allotransplantation.

C.-J. Wen,^1,2 C.-H. Lin,¹ S.-L. Peng,^3,4 F.-N. Wang,³ L.-Y. Huang,³ H.-Y. Cheng,¹ H.-H. Hsu,¹ X.-T. Huang,¹ C.-H. Lin,¹ F.-C. Wei.¹
Therapeutically Equivalent Results to Caucasians in Black Kidney Transplant Recipients Using ASTAGRAF XL^® Despite a Higher Degree of HLA Mismatch : A Post-Hoc Analysis of Phase III Data from Over 2000 Patients.

J. Schwartz, S. Wilson, F. Shi, N. Undre, M. Kumar.
Thoracic Simulated Allocation Modeling (TSAM) of Broader Sharing.

M. Colvin,¹ M. Skeans,¹ L. Robbins Callahan,² L. Edwards,² J. Zeglin,¹ S. Silvestry,³ R. Davies,⁴ M. Farr,⁵ A. Israni,¹ J. Rogers.⁶
Thoracic Simulation Allocation Modeling (TSAM) of a 6-Tier Allocation Strategy.

M. Colvin,¹ M. Skeans,¹ L. Robbins Callahan,² L. Edwards,² J. Zeglin,¹ S. Silvestry,³ R. Davies,⁴ M. Farr,⁵ A. Israni,¹ J. Rogers.⁶
Thorough Pre-Transplant Evaluation and Appropriate Case Selection Is the Mainstay for Better Survival in Recipients with Malignancy.

W. Yin.^1,2
Three Months of Weekly Rifapentine Plus Isoniazid for Latent Tuberculosis Treatment in Solid Organ Transplant Candidates.

B. Knoll,¹ R. Nog,¹ Y. Wu,² A. Dhand.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z